West Pharmaceutical Services Company Profile (NYSE:WST)

About West Pharmaceutical Services

West Pharmaceutical Services logoWest Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company's segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NYSE
  • Symbol: WST
  • CUSIP: 95530610
Key Metrics:
  • Previous Close: $83.75
  • 50 Day Moving Average: $84.68
  • 200 Day Moving Average: $80.70
  • 52-Week Range: $61.94 - $88.30
  • Trailing P/E Ratio: 43.18
  • Foreward P/E Ratio: 28.05
  • P/E Growth: 1.85
  • Market Cap: $6.04B
  • Outstanding Shares: 73,184,000
  • Beta: 0.94
Profitability:
  • Net Margins: 9.27%
  • Return on Equity: 14.54%
  • Return on Assets: 9.30%
Debt:
  • Debt-to-Equity Ratio: 0.20%
  • Current Ratio: 2.78%
  • Quick Ratio: 1.93%
Additional Links:
Companies Related to West Pharmaceutical Services:

Analyst Ratings

Consensus Ratings for West Pharmaceutical Services (NYSE:WST) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $77.28 (6.30% downside)

Analysts' Ratings History for West Pharmaceutical Services (NYSE:WST)
Show:
DateFirmActionRatingPrice TargetDetails
2/21/2017Jefferies Group LLCReiterated RatingHold$82.00View Rating Details
12/23/2016Janney Montgomery ScottReiterated RatingBuyView Rating Details
10/28/2016Wells Fargo & CoUpgradeMarket Perform -> OutperformView Rating Details
(Data available from 3/1/2015 forward)

Earnings

Earnings History for West Pharmaceutical Services (NYSE:WST)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2017        
2/16/2017Q416$0.56$0.54$387.31 million$382.30 millionViewListenView Earnings Details
10/27/2016Q316$0.53$0.53$371.76 million$376.70 millionViewListenView Earnings Details
7/28/2016Q216$0.56$0.59$384.58 million$388.00 millionViewListenView Earnings Details
4/28/2016Q116$0.51$0.53$355.86 million$362.10 millionViewListenView Earnings Details
2/18/2016Q415$0.47$0.47$364.76 million$359.70 millionViewListenView Earnings Details
10/29/2015Q315$0.43$0.44$355.90 million$344.50 millionViewListenView Earnings Details
7/30/2015Q215$0.45$0.47$356.33 million$359.70 millionViewListenView Earnings Details
4/30/2015Q115$0.40$0.45$346.64 million$335.90 millionViewListenView Earnings Details
2/19/2015Q414$0.46$0.45$348.33 million$349.80 millionViewListenView Earnings Details
10/30/2014Q314$0.43$0.44$356.08 million$355.90 millionViewListenView Earnings Details
7/31/2014Q214$0.47$0.52$368.60 million$368.90 millionViewN/AView Earnings Details
5/1/2014Q114$0.41$0.38$340.90 million$346.80 millionViewListenView Earnings Details
2/20/2014Q413$0.38$0.38$348.70 million$342.70 millionViewListenView Earnings Details
10/31/2013Q3 13$0.36$0.39$333.25 million$341.80 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.82$0.86$349.85 million$344.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.86$0.87$344.20 million$339.40 millionViewListenView Earnings Details
2/21/2013Q4 2012$0.56$0.61$318.75 million$321.50 millionViewListenView Earnings Details
11/1/2012Q312$0.50$0.52$306.91 million$303.80 millionViewN/AView Earnings Details
8/2/2012$0.69$0.79ViewN/AView Earnings Details
4/26/2012$0.65$0.83ViewN/AView Earnings Details
2/16/2012$0.55$0.59ViewN/AView Earnings Details
11/1/2011$0.54$0.53ViewN/AView Earnings Details
7/28/2011$0.68$0.62ViewN/AView Earnings Details
4/28/2011$0.62$0.60ViewN/AView Earnings Details
2/17/2011$0.46$0.42ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for West Pharmaceutical Services (NYSE:WST)
Current Year EPS Consensus Estimate: $2.51 EPS
Next Year EPS Consensus Estimate: $2.94 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.52$0.53$0.53
Q2 20161$0.56$0.56$0.56
Q3 20161$0.55$0.55$0.55
Q4 20161$0.56$0.56$0.56
Q1 20171$0.55$0.55$0.55
Q2 20171$0.59$0.59$0.59
Q3 20171$0.68$0.68$0.68
Q4 20171$0.70$0.70$0.70
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for West Pharmaceutical Services (NYSE:WST)
Annual Dividend:$0.52
Dividend Yield:0.63%
Dividend Growth:8.40% (3 Year Average)
Payout Ratio:28.11% (Based on Trailing 12 Months of Earnings)
20.72% (Based on Current Year Consensus EPS Estimate)
17.69% (Based on Next Year Consensus EPS Estimate)
Track Record:24 Years of Consecutive Dividend Growth

Dividend History for West Pharmaceutical Services (NYSE:WST)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/14/2016quarterly$0.130.61%1/13/20171/18/20172/1/2017
9/12/2016quarterly$0.1310/17/201610/19/201611/2/2016
7/6/2016Quarterly$0.127/18/20167/20/20168/3/2016
3/4/2016Quarterly$0.124/18/20164/20/20165/4/2016
12/17/2015Quarterly$0.121/15/20161/20/20162/3/2016
7/15/2015quarterly$0.120.79%10/19/201510/21/201511/4/2015
7/2/2015quarterly$0.110.76%7/20/20157/22/20158/5/2015
2/20/2015quarterly$0.110.82%4/20/20154/22/20155/6/2015
12/22/2014quarterly$0.110.81%1/16/20151/21/20152/4/2015
7/16/2014quarterly$0.1110/20/201410/22/201411/5/2014
7/16/2014quarterly$0.111.11%10/15/201410/19/201411/3/2014
5/8/2014quarterly$0.100.94%7/21/20147/23/20148/6/2014
2/20/2014quarterly$0.100.83%4/21/20144/23/20145/7/2014
12/19/2013quarterly$0.100.81%1/17/20141/22/20142/5/2014
8/1/2013quarterly$0.2010/23/201311/6/2013
5/10/2013quarterly$0.191.16%7/22/20137/24/20138/7/2013
3/15/2013quarterly$0.191.21%4/15/20134/17/20135/1/2013
12/27/2012quarterly$0.191.4%1/18/20131/23/20132/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for West Pharmaceutical Services (NYSE:WST)
Insider Ownership Percentage: 5.13%
Institutional Ownership Percentage: 90.31%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/8/2016Patrick J. ZennerDirectorBuy332$84.53$28,063.96View SEC Filing  
10/31/2016Paula A. JohnsonDirectorSell2,466$75.87$187,095.42View SEC Filing  
9/6/2016Karen FlynnSVPSell14,581$83.28$1,214,305.68View SEC Filing  
8/23/2016Paula A JohnsonDirectorSell3,042$81.55$248,075.10View SEC Filing  
6/2/2016Daniel MaloneVPSell3,950$74.95$296,052.50View SEC Filing  
5/25/2016Thomas W HofmannDirectorSell2,466$73.57$181,423.62View SEC Filing  
3/1/2016Michael A AndersonVPSell16,414$63.58$1,043,602.12View SEC Filing  
2/29/2016Thomas W HofmannDirectorSell3,042$62.70$190,733.40View SEC Filing  
2/25/2016Heino LennartzInsiderSell5,680$62.47$354,829.60View SEC Filing  
2/24/2016Heino LennartzInsiderSell19,658$59.45$1,168,668.10View SEC Filing  
2/23/2016Paula A. JohnsonDirectorSell7,800$59.39$463,242.00View SEC Filing  
2/22/2016Warwick BedwellInsiderSell16,042$59.52$954,819.84View SEC Filing  
11/25/2015John E. PaproskiinsiderSell17,560$63.41$1,113,479.60View SEC Filing  
11/12/2015Heino LennartzInsiderSell3,500$61.87$216,545.00View SEC Filing  
11/6/2015Michael A AndersonVPSell3,000$62.18$186,540.00View SEC Filing  
11/5/2015Michael A. AndersonVPSell10,000$61.98$619,800.00View SEC Filing  
11/4/2015Daniel MaloneVPSell4,456$61.65$274,712.40View SEC Filing  
8/17/2015William J FedericiCFOSell52,678$59.72$3,145,930.16View SEC Filing  
5/28/2015Heino LennartzInsiderSell9,584$55.00$527,120.00View SEC Filing  
5/22/2015Karen FlynnInsiderSell3,091$55.24$170,746.84View SEC Filing  
5/21/2015Eric Mark GreenCEOBuy18,300$54.89$1,004,487.00View SEC Filing  
5/18/2015Karen FlynnInsiderSell1,909$55.00$104,995.00View SEC Filing  
5/15/2015Donald E Morel JrCEOSell20,000$54.29$1,085,800.00View SEC Filing  
2/27/2015Richard D LuzziVPSell10,000$54.85$548,500.00View SEC Filing  
2/26/2015Michael A AndersonVPSell4,682$54.93$257,182.26View SEC Filing  
2/25/2015Heino LennartzInsiderSell3,617$54.82$198,283.94View SEC Filing  
2/24/2015John E PaproskiInsiderSell9,282$52.87$490,739.34View SEC Filing  
2/23/2015Heino LennartzInsiderSell21,040$53.40$1,123,536.00View SEC Filing  
2/23/2015Patrick J ZennerDirectorSell12,800$53.69$687,232.00View SEC Filing  
11/26/2014Richard D LuzziVPSell8,000$52.11$416,880.00View SEC Filing  
11/21/2014William J FedericiCFOSell3,000$51.22$153,660.00View SEC Filing  
11/20/2014Donald E Morel JrCEOSell20,000$51.30$1,026,000.00View SEC Filing  
11/13/2014John R GaileyVPSell28,000$52.37$1,466,360.00View SEC Filing  
11/11/2014Michael A AndersonVPSell4,600$51.73$237,958.00View SEC Filing  
11/10/2014Warwick BedwellInsiderSell6,306$49.95$314,984.70View SEC Filing  
8/21/2014Richard D LuzziVPSell10,000$44.07$440,700.00View SEC Filing  
8/20/2014John R GaileyVPSell20,000$43.96$879,200.00View SEC Filing  
8/19/2014Michael A AndersonVPSell9,800$43.41$425,418.00View SEC Filing  
8/18/2014William J FedericiCFOSell38,366$42.56$1,632,856.96View SEC Filing  
8/13/2014Heino LennartzInsiderSell7,555$39.65$299,555.75View SEC Filing  
8/11/2014Heino LennartzInsiderSell11,445$40.00$457,800.00View SEC Filing  
8/7/2014John E PaproskiInsiderSell14,000$40.44$566,160.00View SEC Filing  
5/30/2014Richard D LuzziVPSell22,828$42.17$962,656.76View SEC Filing  
5/29/2014Heino LennartzInsiderSell2,000$43.00$86,000.00View SEC Filing  
2/28/2014Heino LennartzInsiderSell16,044$45.84$735,456.96View SEC Filing  
2/26/2014Patrick J ZennerDirectorSell12,800$46.12$590,336.00View SEC Filing  
2/24/2014Warwick BedwellInsiderSell24,606$47.49$1,168,538.94View SEC Filing  
11/26/2013Donald E Morel JrCEOSell35,000$48.60$1,701,000.00View SEC Filing  
11/22/2013William J FedericiCFOSell36,000$48.34$1,740,240.00View SEC Filing  
11/19/2013Karen FlynnInsiderSell5,500$47.75$262,625.00View SEC Filing  
11/8/2013Michael A AndersonVPSell9,200$46.80$430,560.00View SEC Filing  
11/7/2013Heino LennartzInsiderSell5,102$46.70$238,263.40View SEC Filing  
11/6/2013Michael A AndersonVPSell6,000$46.53$279,180.00View SEC Filing  
11/5/2013John R GaileyVPSell6,000$46.83$280,980.00View SEC Filing  
11/5/2013Warwick BedwellInsiderSell6,304$46.84$295,279.36View SEC Filing  
11/4/2013Richard D LuzziVPSell38,708$46.99$1,818,888.92View SEC Filing  
8/30/2013Donald E Morel JrCEOSell10,000$74.46$744,600.00View SEC Filing  
8/27/2013John R GaileyVPSell13,749$76.77$1,055,510.73View SEC Filing  
8/22/2013L Robert JohnsonDirectorSell1,883$76.81$144,633.23View SEC Filing  
8/14/2013John E PaproskiInsiderSell6,011$79.08$475,349.88View SEC Filing  
8/12/2013Anthony WeltersDirectorSell19,200$78.43$1,505,856.00View SEC Filing  
8/8/2013Michael A AndersonVPSell4,300$78.00$335,400.00View SEC Filing  
5/31/2013Michael A AndersonVPSell4,000$68.94$275,760.00View SEC Filing  
5/28/2013Donald E Morel JrCEOSell10,000$67.87$678,700.00View SEC Filing  
5/24/2013L Robert JohnsonDirectorSell1,700$67.47$114,699.00View SEC Filing  
5/20/2013John R GaileyVPSell9,282$68.54$636,188.28View SEC Filing  
5/17/2013L Robert JohnsonDirectorSell4,000$67.80$271,200.00View SEC Filing  
5/8/2013L Robert JohnsonDirectorSell6,400$64.49$412,736.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for West Pharmaceutical Services (NYSE:WST)
DateHeadline
biz.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Files SEC form 10-K, Annual Report (NYSE:WST)
biz.yahoo.com - February 28 at 8:28 PM
4-traders.com logoWest Pharmaceutical Services : Fran DeGrazio Presents on The Changing Regulatory Environment -- Pharmapack 2017 (NYSE:WST)
www.4-traders.com - February 27 at 5:31 PM
4-traders.com logoWest Pharmaceutical Services : NovaPure® Plungers for Biologic Applications (NYSE:WST)
www.4-traders.com - February 25 at 4:31 AM
News IconLooking at the Levels for West Pharmaceutical Services, Inc. (NYSE:WST) - Rives Journal (NYSE:WST)
rivesjournal.com - February 24 at 12:17 AM
News IconSell-side Taking Aim at Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Aiken Advocate (NYSE:WST)
aikenadvocate.com - February 24 at 12:17 AM
News IconLarge Outflow of Money Witnessed in West Pharmaceutical Services, Inc. - Money Flow Index & Trends (NYSE:WST)
www.moneyflowtrends.com - February 24 at 12:17 AM
News IconCompany Spotlight on Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Providence Standard (NYSE:WST)
providencestandard.com - February 21 at 4:15 PM
News IconStock Review: Level Check for West Pharmaceutical Services, Inc. (NYSE:WST) - Rives Journal (NYSE:WST)
rivesjournal.com - February 21 at 4:15 PM
capitalcube.com logoWest Pharmaceutical Services, Inc. :WST-US: Earnings Analysis: 2016 By the Numbers : February 21, 2017 (NYSE:WST)
www.capitalcube.com - February 21 at 4:15 PM
prnewswire.com logoWest Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend - PR Newswire (press release) (NYSE:WST)
www.prnewswire.com - February 18 at 7:39 PM
biz.yahoo.com logoWest Pharmaceutical Services Inc Earnings Call (Q4 2016) (NYSE:WST)
biz.yahoo.com - February 17 at 5:15 PM
4-traders.com logoWEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Results of Operations and Financial Condition (NYSE:WST)
www.4-traders.com - February 17 at 5:15 PM
News IconWant to invest in West Pharmaceutical Services Inc (WST) today? Read this before (NYSE:WST)
simplywall.st - February 17 at 5:15 PM
seekingalpha.com logoWest Pharmaceutical Services Inc. 2016 Q4 - Results - Earnings Call Slides (NYSE:WST)
seekingalpha.com - February 17 at 5:15 PM
us.rd.yahoo.com logoWest Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend (NYSE:WST)
us.rd.yahoo.com - February 17 at 5:15 PM
biz.yahoo.com logoQ4 2016 West Pharmaceutical Services Inc Earnings Release - Before Market Open (NYSE:WST)
us.rd.yahoo.com - February 17 at 5:15 PM
us.rd.yahoo.com logo7:08 am West Pharm misses by $0.02, misses on revs; guides FY17 EPS in-line, revs in-line (NYSE:WST)
us.rd.yahoo.com - February 17 at 5:15 PM
capitalcube.com logoWest Pharmaceutical Services, Inc. :WST-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017 (NYSE:WST)
www.capitalcube.com - February 17 at 5:15 PM
seekingalpha.com logoWest Pharmaceutical's (WST) CEO Eric Green on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:WST)
seekingalpha.com - February 17 at 8:30 AM
sg.finance.yahoo.com logoWest Pharmaceutical misses Street 4Q forecasts (NYSE:WST)
sg.finance.yahoo.com - February 17 at 8:30 AM
biz.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Dis (NYSE:WST)
biz.yahoo.com - February 17 at 8:30 AM
biz.yahoo.com logoWest Pharmaceutical Services Inc Earnings Call scheduled for 9:00 am ET today (NYSE:WST)
biz.yahoo.com - February 17 at 8:30 AM
finance.yahoo.com logoEdited Transcript of WST earnings conference call or presentation 16-Feb-17 2:00pm GMT (NYSE:WST)
finance.yahoo.com - February 17 at 8:30 AM
4-traders.com logoWest Pharmaceutical Services : Launches 20 mm Plastic Closure at PharmaPack (NYSE:WST)
www.4-traders.com - February 15 at 6:57 AM
finance.yahoo.com logoWest to Host Fourth-Quarter and Full-Year 2016 Conference Call (NYSE:WST)
finance.yahoo.com - February 3 at 6:48 AM
News IconWest Introduces LyoSeal® and NovaGuard® SA Pro at Pharmapack Europe (NYSE:WST)
www.packagingeurope.com - February 2 at 6:51 AM
prnewswire.com logoWest Introduces LyoSeal® Instant Sealing Solution and NovaGuard® SA Pro Safety System at Pharmapack Europe - PR Newswire (press release) (NYSE:WST)
www.prnewswire.com - February 1 at 7:29 AM
finance.yahoo.com logoWest Introduces LyoSeal® Instant Sealing Solution and NovaGuard® SA Pro Safety System at Pharmapack Europe (NYSE:WST)
finance.yahoo.com - February 1 at 7:29 AM
finance.yahoo.com logoBaron Asset Fund Comments on West Pharmaceutical Services (NYSE:WST)
finance.yahoo.com - January 31 at 8:09 AM
News IconWest Pharmaceuticals Services (WST) Holder Kalmar Investments INC Trimmed Position as Market Valuation Declined (NYSE:WST)
randolphguide.com - January 28 at 2:40 AM
News IconStock Update: Estimates & Target in Focus for West Pharmaceutical Services, Inc. (NYSE:WST) - Aiken Advocate (NYSE:WST)
aikenadvocate.com - January 27 at 6:48 AM
capitalcube.com logoWest Pharmaceutical Services, Inc. – Value Analysis (NYSE:WST) : January 25, 2017 (NYSE:WST)
www.capitalcube.com - January 26 at 6:32 AM
capitalcube.com logoWest Pharmaceutical Services, Inc. breached its 50 day moving average in a Bearish Manner : WST-US : January 24, 2017 (NYSE:WST)
www.capitalcube.com - January 24 at 3:32 PM
capitalcube.com logoETFs with exposure to West Pharmaceutical Services, Inc. : January 20, 2017 (NYSE:WST)
www.capitalcube.com - January 20 at 3:49 PM
News IconWhat are Analysts Expecting for West Pharmaceutical Services, Inc. (NYSE:WST) Earnings? - Aiken Advocate (NYSE:WST)
aikenadvocate.com - January 20 at 2:26 AM
News IconLive Stock Coverage: West Pharmaceutical Services Inc (NYSE:WST) Quarterly Sentiment Report - Baxley Report (NYSE:WST)
baxleyreport.com - January 19 at 8:02 AM
News IconFirms & Funds Reinforcing Their Perception of West Pharmaceutical Services, Inc. (NYSE:WST) - Wall Street Beacon (NYSE:WST)
wsbeacon.com - January 18 at 5:38 AM
nasdaq.com logoWest Pharmaceutical Services, Inc. (WST) Ex-Dividend Date Scheduled for January 13, 2017 - Nasdaq (NYSE:WST)
www.nasdaq.com - January 13 at 6:49 AM
News IconInvestor Focus: Watching Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Wall Street Beacon (NYSE:WST)
wsbeacon.com - January 12 at 8:07 AM
News IconInvestor List: Watching Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Wall Street Beacon (NYSE:WST)
wsbeacon.com - January 12 at 8:07 AM
biz.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSE:WST)
biz.yahoo.com - January 12 at 8:07 AM
forbes.com logoWest Pharmaceutical Services About To Put More Money In Your Pocket (WST) (NYSE:WST)
www.forbes.com - January 11 at 11:01 AM
News IconWhat You Must Know About West Pharmaceutical Services Inc's ... - Simply Wall St (NYSE:WST)
simplywall.st - January 9 at 3:19 PM
News IconMarket Center: Watching the Levels for West Pharmaceutical Services, Inc. (NYSE:WST) - Wall Street Beacon (NYSE:WST)
wsbeacon.com - January 9 at 3:19 PM
reuters.com logoBRIEF-West Pharmaceutical Services, Daikyo Seiko enter amended and restated technology exchange (NYSE:WST)
www.reuters.com - January 7 at 6:33 AM
biz.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Entry into a Material Definitive Agreement (NYSE:WST)
biz.yahoo.com - January 7 at 6:33 AM
News IconMarket Survey: Checking on Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Wall Street Beacon (NYSE:WST)
wsbeacon.com - January 5 at 7:36 AM
prnewswire.com logoWest to Present at J.P. Morgan Healthcare Conference - PR Newswire (press release) (NYSE:WST)
www.prnewswire.com - December 30 at 3:28 AM
4-traders.com logoWest Pharmaceutical Services : to Present at J.P. Morgan Healthcare Conference (NYSE:WST)
www.4-traders.com - December 28 at 8:04 AM
finance.yahoo.com logoWest to Present at J.P. Morgan Healthcare Conference (NYSE:WST)
finance.yahoo.com - December 28 at 8:04 AM

Social

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Wednesday, December 14th. Investors of record on Wednesday, January 18th will be paid a dividend of $0.13 per share on Wednesday, February 1st. This represents a $0.52 annualized dividend and a yield of 0.63%. The ex-dividend date is Friday, January 13th.

Where is West Pharmaceutical Services' stock going? Where will West Pharmaceutical Services' stock price be in 2017?

3 analysts have issued twelve-month price objectives for West Pharmaceutical Services' shares. Their predictions range from $72.55 to $82.00. On average, they expect West Pharmaceutical Services' stock price to reach $77.28 in the next twelve months.

When will West Pharmaceutical Services announce their earnings?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, April, 27th 2017.

What are analysts saying about West Pharmaceutical Services stock?

Here are some recent quotes from research analysts about West Pharmaceutical Services stock:

  • According to Zacks Investment Research, "West Pharmaceutical Services applies technologies to the process of bringing new drug therapies and healthcare products. West's technologies include the design and manufacture of packaging components for pharmaceutical, healthcare and consumer products; research and development of drug delivery systems; contract manufacturing and packaging services; clinical services; and contract laboratory services and other services that support the manufacturing, filling and packaging of pharmaceutical, healthcare and consumer products. " (2/24/2017)

  • Jefferies Group LLC analysts commented, "WST's formal '17 guidance featured a 1% higher CC revenue growth (7-9% from 6-8%) and continued margin expansion driven by high-value product growth. But that wasn't enough. At 33x '17, we thought the market discounted inflecting EPS growth, which has made valuation look stretched to us. FX headwinds ($35-45M; $0.05-0.07) and slightly rising tax rate negate the faster top-line. Maintain Hold." (2/21/2017)

Who owns West Pharmaceutical Services stock?

West Pharmaceutical Services' stock is owned by a number of of retail and institutional investors. Top institutional investors include Franklin Resources Inc. (5.40%), State Street Corp (3.48%), Columbia Wanger Asset Management LLC (0.83%), AQR Capital Management LLC (0.77%), Ruane Cunniff & Goldfarb Inc. (0.51%) and Dimensional Fund Advisors LP (0.51%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Donald E Morel Jr, Eric Mark Green, Heino Lennartz, John E Paproski, Karen Flynn, Michael A Anderson, Patrick J Zenner, Paula A Johnson, Thomas W Hofmann, Warwick Bedwell and William J Federici.

Who sold West Pharmaceutical Services stock? Who is selling West Pharmaceutical Services stock?

West Pharmaceutical Services' stock was sold by a variety of institutional investors in the last quarter, including Columbia Wanger Asset Management LLC, Federated Investors Inc. PA, Ruane Cunniff & Goldfarb Inc., Thrivent Financial for Lutherans, Dimensional Fund Advisors LP, Allianz Asset Management AG, Franklin Resources Inc. and Janus Capital Management LLC. Company insiders that have sold West Pharmaceutical Services stock in the last year include Daniel Malone, Karen Flynn, Michael A Anderson, Paula A Johnson and Thomas W Hofmann.

Who bought West Pharmaceutical Services stock? Who is buying West Pharmaceutical Services stock?

West Pharmaceutical Services' stock was acquired by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, State Street Corp, Sandler Capital Management, Shelton Capital Management, Royce & Associates LP, Highland Capital Management LP, Nicholas Investment Partners LP and Employees Retirement System of Texas. Company insiders that have bought West Pharmaceutical Services stock in the last two years include Eric Mark Green and Patrick J Zenner.

How do I buy West Pharmaceutical Services stock?

Shares of West Pharmaceutical Services can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of West Pharmaceutical Services stock cost?

One share of West Pharmaceutical Services stock can currently be purchased for approximately $82.47.

West Pharmaceutical Services (NYSE:WST) Chart for Wednesday, March, 1, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Earnings History Chart

Earnings by Quarter for West Pharmaceutical Services (NYSE:WST)

Dividend History Chart

Dividend Payments by Quarter for West Pharmaceutical Services (NYSE:WST)

Last Updated on 3/1/2017 by MarketBeat.com Staff